These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice. McCoy KL; Kendrick L; Chused TM J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456 [TBL] [Abstract][Full Text] [Related]
26. Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle. Colafrancesco S; Agmon-Levin N; Perricone C; Shoenfeld Y Immunol Res; 2013 Jul; 56(2-3):200-5. PubMed ID: 23733136 [TBL] [Abstract][Full Text] [Related]
27. [Photopheresis: new immunomodulatory therapy for T-lymphocite mediated diseases]. Vagace Valero JM; Alonso Escobar N; De Argila Fernández-Durán D; Vargas Pérez L; Melero Ruiz J; Morán Penco JM; Bajo Gómez R; Pérez Miranda M An Med Interna; 2003 Aug; 20(8):421-6. PubMed ID: 14516265 [TBL] [Abstract][Full Text] [Related]
29. Thymic hormone in the treatment of cancer. Dardeene M; Bach JF Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955 [No Abstract] [Full Text] [Related]
30. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. Steinberg BJ; Smathers PA; Frederiksen K; Steinberg AD J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900 [TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory effects of neurotropin through the recovery of interleukin-2 production in autoimmune-prone (NZB/NZW) F1 mice. Naiki M; Suehiro S; Imai Y; Osawa T Int J Immunopharmacol; 1989; 11(6):663-71. PubMed ID: 2807638 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of rheumatism with hormonal preparations]. ORLOVA AN Ter Arkh; 1955; 27(7):75-84. PubMed ID: 13299157 [No Abstract] [Full Text] [Related]